Clinical Trial Update: A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether adding steroids to intravenous immunoglobulin can prevent coronary artery abnormalities in Taiwanese patients with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kawasaki Disease

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)
• Steroid (steroid)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Kawasaki Disease, Steroid | Phase 3 | Status: UNKNOWN